Globe Group Transforms Healthcare Access In The Philippines With KonsultaMD SuperApp

KUALA LUMPUR, May 30 (Bernama) — The Globe Group, a leading digital solutions platform in the Philippines, has achieved a major milestone in its health tech initiative with the recent launch of the KonsultaMD SuperApp.

In a statement, the company said this groundbreaking app showcased new capabilities and a deeper and broader provider network, marking a significant advancement in the country’s healthcare industry.

“We have very exciting plans for KonsultaMD. It seeks to address a very big issue in the Philippines. With a ratio of one doctor for every 30,000 citizens, bringing healthcare access to the public is really our goal.

“The more we make the SuperApp easy to use and inject many more services into it, we think it is going to resonate with our customers and the public,” said Globe Group President and Chief Executive Officer, Ernest Cu.

The SuperApp is the next-generation iteration of KonsultaMD, a telehealth platform established by the Globe Group in 2015 that has since been instrumental in digitising healthcare services in the Philippines.

It bridges the gap between various health and medical services, consolidating them into one cohesive platform. This feature is particularly beneficial for those residing in remote areas where access to doctors is limited or none at all.

Bringing together services of top medical apps KonsultaMD, HealthNow and AIDE, the SuperApp features doctor consultations, a 24/7 online pharmacy with same-day delivery, at-home lab testing, diagnostics, wellness services, and physical therapy, among others.

The app also empowers users to consult with over 1,000 medical professionals with more than 40 specialisations including mental health, through on-demand video or chat from the comfort of their own homes.

The KonsultaMD SuperApp exemplifies the Globe’s commitment to making healthcare accessible to all, with plans for further expansion and improvement.

— BERNAMA

TIAD, AUTOGRAPH COLLECTION HOTEL IN NAGOYA, JAPAN OPENS FOR ONLINE RESERVATIONS

KUALA LUMPUR, May 25 (Bernama) — Nihon Ceremony Inc announced that online reservations have begun for TIAD, Autograph Collection, the new hotel scheduled to open this July in Nagoya, Japan.

Operated by Nihon Ceremony, the hotel will represent the fourth Japan-based addition to Marriott International’s Autograph Collection (R), and the first in the Nagoya area (as of May 2023).

Autograph Collection hotels advocates for the original, championing the individuality of each of its over 270 independent hotels located in the most desirable destinations across more than 45 countries and territories.

According to a statement, each hotel is a product of passion, inspired by a clear vision, soul and story that makes it individual and special “Exactly Like Nothing Else”.

Hand-selected for their inherent craft and distinct perspectives on design and hospitality, Autograph Collection properties offer rich immersive moments that leave a lasting imprint.

TIAD has 14 classes of guest rooms in three room categories, with all rooms providing over 50 square metre of floor space.

Among others, the Euphoria Deluxe Twin Park View room faces Hisaya-odori Park where guests can enjoy the greenery of the park and the seasonal scenery from the floor-to-ceiling window, while the Euphoria Premier King Park View has a balcony that overlooks the leafy Hisaya-odori Park in which guests can enjoy four seasons through the bathroom window while relaxing in the bath.

In addition, the 96 square metre Suite is located in the southwest corner of the building, facing leafy Hisaya-odori Park, while the Presidential Suite, located in the northwest corner of the 14th floor, feature a walk-in closet, balcony and large bathroom with steam sauna, promises a top-quality stay in the region.

Guests will also be able to use the exclusive wellness zone, featuring an indoor swimming pool, fitness centre, and wellness lounge serving fresh smoothies and snacks.

More details at https://hotel-tiad.com/english.

— BERNAMA

YILI UNVEILS THE WISH2030 DECLARATION, TOGETHER WITH ITS GLOBAL PARTNERS, AT THE GROUP’S ESG AND SOCIAL VALUE FORUM

AsiaNet 100103

Yili unveils the WISH2030 Declaration

HOHHOT, China, May 24, 2023 /Xinhua-AsiaNet/–

On May 22, which celebrates the International Day for Biological Diversity, Asian dairy giant Yili Group held its “ESG and Social Value Forum” and officially released three new ESG reports: the 2022 Sustainability Report, the 2022 Annual Report on Biodiversity Conservation, and the Net-Zero Carbon Future Report 2022.

The forum was held at the Yili Modern Intelligent Health Valley, which is widely known as the “Dairy Silicon Valley”. Together with its global partners, Yili unveiled the WISH2030 Declaration for a Sustainable Future, calling for the entire industry to work together to create value and build a better future. At the forum, Pan Gang, Chairman and President of Yili Group, underscored Yili’s longstanding commitment to always adhere to the principles of altruism and ensure positive long-term development. The company is dedicated to uniting diverse stakeholders to establish a “global health ecosystem” and enable the business community and wider society to enjoy mutual prosperity.

In 2007, Yili became the first private company in China to publish a corporate citizenship report, and the Group’s concept of “green leadership” has received growing recognition globally ever since. From Yili’s debut at the inaugural Summer Davos in 2007 to its pioneering role as the first Chinese food company to join the United Nations Global Compact, Yili has also actively participated in the COP13, COP14, and COP15 Conferences of the Convention on Biological Diversity, demonstrating its dynamic commitments aimed at supporting sustainable development worldwide.

In 2023, Yili released its 17th consecutive sustainability report. The Group’s latest report received a “five-star” rating from the Chinese Expert Committee on Corporate Social Responsibility Report Rating and has also been highly recognized by the United Nations. Liu Meng, Head of the China Office of the United Nations Global Compact, commended Yili for having actively responded to the United Nations’ call for businesses to address major sustainability challenges and emphasized how the company’s efforts have proven conducive to promoting and empowering more enterprises and industries to achieve sustainable high-quality development.

This year, Yili upgraded its “WISH” system to the “WISH2030” Golden Key Sustainable Development System, which prioritizes four major areas: “Comprehensive Value Management”, “High-Quality Products and Services”, “A Net-Zero Carbon Better Future”, and “Shared Prosperity of a Better Life”.

Qian Xiaojun, Director of the Research Center for Green Economy and Sustainable Development at Tsinghua University, pointed out that Yili has successfully maintained business growth for 30 consecutive years. Even in the challenging and uncertain year of 2022, Yili’s total revenue achieved year-on-year growth of more than 11%, while its net profit attributable to the parent company realized year-on-year growth of more than 8%. The robust growth figures reflect the strength of the company’s ‘long-termism’ values.

In celebration of the International Day for Biological Diversity, Yili once again joined forces with the World Wildlife Fund (WWF) to launch the “Yili Homeland Initiative: Satine Empty Carton Recycling Plan” while also releasing a limited-edition packaging featuring unique animal species that inhabit grasslands and wetlands. Lu Lunyan, Chief Representative of the WWF Beijing Office, said, “The health of nature directly affects human well-being. The WWF and Yili are dedicated to continuing actively supporting conservation and development, safeguarding the health of biodiversity, and improving people’s well-being.” For every 2,000 empty Satine milk cartons that are successfully recycled, a home can be created for grassland and wetland animals.

Source: Yili Group

Image Attachments Links:

   Link: https://iop.asianetnews.net/view-attachment?attach-id=440890

   Caption: Pan Gang, Chairman and President of Yili Group

   Link: https://iop.asianetnews.net/view-attachment?attach-id=440897

   Caption: Yili unveils the WISH2030 Declaration

MINISO LAUNCHES FLAGSHIP STORE IN TIMES SQUARE, NEW YORK


KUALA LUMPUR, May 23 (Bernama) — Lifestyle retailer MINISO opened its new global flagship store at New York’s iconic Times Square, marking a major milestone in the brand’s history, on May 19.

According to MINISO in a statement, the new store brings its signature joyful attitude and fun, affordable, well-designed products straight to the heart of one of the world’s most famous shopping districts.

“Establishing a presence in one of the world’s most recognisable commercial and culture destinations allows us to effectively reach new audiences on a daily basis, introducing our fun, quality products to the hundreds of thousands of New Yorkers and tourists who pass through these streets every single day,” said MINISO Founder and Chief Executive Officer, Jack Ye.

Located on the first floor of 5 Times Square, the new flagship has a bright and clean look, with the eye being drawn to MINISO’s licensed collections with some of the world’s best-known intellectual property owners.

From Sanrio to We Bare Bears, the licensed collections are just some of the 2,500 products on offer in the new store, laid out across ten dedicated product zones, including blind box collectibles, toys, plushies, fragrances, accessories, makeup tools, snacks, electronics as well as gifts & stationery.

The diverse range of products and MINISO’s engaging shopping experience proved a hit, with the store generating nearly US$80,000 in sales over the course of the opening day, setting a new single-day sales record among all stores globally. (US$1=RM4.54)

The opening of the new flagship in Times Square this year, the brand’s 10th anniversary year, comes shortly after the announcement of a new global strategy, which aims to transform MINISO into a lifestyle super brand.

The Times Square new flagship store not only promises to boost this transformation, but also showcases MINISO’s strong commitment to establishing a thriving presence in the United States (US) market. With over 70 stores and a dedicated team of local staff, the US market has emerged as MINISO’s top-performing overseas market for two consecutive quarters.

Looking ahead, MINISO will maintain a steadfast focus on product innovation and store operations, delivering a treasure-hunt shopping experience for customers with an array of captivating licensed collection zones within its stores, and has also set ambitious goals to surpass 100 stores in the US by the end of 2023.

Since its founding in 2013, MINISO has won fans across 106 markets with more than 5,514 stores to date, attracting over one billion customers globally, and the new flagship ensures that the brand will be able to reach even more customers from even more corners of the globe.

— BERNAMA

OMRON HEALTHCARE CELEBRATES 50 YEARS OF BLOOD PRESSURE MONITOR HISTORY

AsiaNet 100094

KYOTO, Japan, May 23, 2023 /Kyodo JBN-AsiaNet/ —

OMRON Healthcare Co., Ltd. (hereinafter referred to as the Company) based in Muko City, Kyoto Prefecture, Japan, is proud to announce the celebration of its 50th anniversary in blood pressure monitor production this year. Since the introduction of its first manual and manometer-type blood pressure monitor in 1973, the Company has continuously improved and produced accurate and user-friendly blood pressure monitors. To date, the Company has sold over 350 million units in more than 110 countries worldwide.

Logo: https://kyodonewsprwire.jp/img/202305165636-O5-THg59uEz

The Company has always believed in the importance of home blood pressure monitoring, even when blood pressure readings could only be obtained at medical facilities. In 1991, the Company launched the world’s first automated blood pressure monitor with fuzzy logic technology (*) for greater accuracy and ease of use than manual monitors. In parallel with the advancement of blood pressure monitors, the Company worked continuously to improve and developed the pre-formed cuff that the user can wrap around his/her arm securely and easily. Moreover, the Company has been focusing on enhancing usability and measurement accuracy by expanding the range of support functions to ensure that the user maintains the correct measurement posture.
(*) Automatic pressure-setting function

Image1: The first blood pressure monitor: HEP-1
https://kyodonewsprwire.jp/img/202305165636-O1-9z3sXW19

Image2: The world’s first fuzzy logic automatic blood pressure monitor: HEM-706
https://kyodonewsprwire.jp/img/202305165636-O6-uDd2KOhG

In addition, the Company has worked to raise awareness of the importance of home blood pressure monitoring among medical professionals by developing and distributing the accurate and clinically validated devices. The Company supported the Ohasama Study, which was started in 1986 in Ohasama, Iwate Prefecture, by providing around 300 units of OMRON blood pressure monitors for use in the research. Ohasama was notable for high and increasing incidence rates of cardiovascular diseases due to the area’s cold climate. To counter this problem, public health nurses worked to improve the community’s health by having its residents measure their blood pressure at home and advising them based on their self-measured day-to-day blood pressure data. This study continued for more than 35 years and its findings, which confirmed the benefits of home blood pressure monitoring, have been incorporated into hypertension management guidelines issued in various countries.

The Company has continued to pursue the challenge of adopting digital technology for blood pressure management. In 2010, the Company launched a health management service, WellnessLINK, on the Japanese market. The smartphone app for health management, OMRON connect, is now available in more than 140 countries. Moreover, in 2020, the Company launched a remote patient monitoring service in the U.S. This service enables users to share their blood pressure readings at home with physicians, promoting cardiovascular disease management before it worsens. The Company has expanded its business scope by manufacturing and distributing a range of products and services that support hypertension treatments.

The Company is also committed to developing innovative devices. These developments include the world’s first clinically accurate wearable blood pressure monitor, HeartGuide, and an upper-arm blood pressure monitor with built-in electrocardiogram (ECG) technology to facilitate the early detection of atrial fibrillation, a known risk factor for cardiogenic brain embolism.

Image3: Wearable blood pressure monitor: HCR-6900T-M
https://kyodonewsprwire.jp/img/202305165636-O3-gUNRLxNb

Image4: Upper-arm blood pressure monitor with ECG: HCR-7800T
https://kyodonewsprwire.jp/img/202305165636-O4-Bu8sRho7

“This year, we are celebrating the 50th anniversary of the launch of OMRON blood pressure monitors,” said Ayumu Okada, President and CEO of OMRON Healthcare Co., Ltd. “On this occasion, I would like to express my heartfelt appreciation to all our valued customers for their continuing support of our blood pressure monitors. Cerebro-cardiovascular diseases are known to be the leading cause of death globally, and as populations in many countries continue to age, the number of patients suffering from these diseases is expected to increase even more. We remain committed to fulfilling the vision of ‘Going for ZERO’ (achieving zero cerebro-cardiovascular events). Going forward, we will continue contributing to extending healthy life expectancy for people around the world by introducing devices and services tailored to solving health-related issues.”

History of blood pressure monitor development
For the detailed information of the Company’s achievements and the future vision for realizing the vision of zero cerebrovascular and cardiovascular events, please visit here:
https://healthcare.omron.com/healthcare-solutions/cardiovascular-health/300-million/our-journey/history-of-home-bpm


Source: OMRON Healthcare Co., Ltd.